Although a recent study of 20,000 COVID-19 patients had found convalescent plasma a safe treatment, the letter said, "the FDA initially chose to hold off on issuing an EUA for blood plasma after top government scientists - including [the NIH's] Dr. Anthony Fauci and Dr. Francis Collins - publicly urged the FDA to wait before reviewing more convincing effectiveness data." But then politics kicked in, the letter claimed, and the EUA was granted.
 No Comments
 Coronavirus BioWorld BioWorld MedTech U.S. Regulatory FDA NIH
 KEYWORDS convalescent plasma COVID-19 emergency use authorization EUA SARS- CoV-2
 Mari Serebrov
 # Making CEOs the Scapegoat
 More from this author


--DocBreak--
trb.privacy.processQ())};
   *[ASX]: Australian Stock Exchange


--DocBreak--
ASX]: Australian Stock Exchange

